Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

Gregg L. Semenza, M.D., Ph.D.

Research summary

Gregg L. Semenza, M.D., Ph.D.
Gregg L. Semenza, M.D., Ph.D.

The Semenza lab studies molecular mechanisms underlying angiogenesis and vascular remodeling in ischemic cardiovascular disease. A major aspect of this process is the production of multiple angiogenic cytokines and growth factors in response to hypoxia/ischemia, which is mediated by the transcription factor HIF-1 (hypoxia-inducible factor 1). HIF-1 mediates vascular and progenitor cell responses to angiogenic signals, but these processes are impaired by aging and diabetes. The team currently is studying the use of gene and stem cell therapy in mouse models of critical limb ischemia and cutaneous burn wounds.

HIF-1 plays important roles in critical aspects of cancer biology, including tumor angiogenesis, regulation of glucose and energy metabolism, invasion, and metastasis. The team is taking several approaches to inhibit HIF-1 activity, including RNA interference, dominant negative constructs, and small molecule inhibitors. A major focus of their current cancer research is using animal, cell-based, molecular, and biophysical approaches to investigate the role of HIF-1 in vascular and lymphatic metastasis of human breast cancer.

HIF-1 also is required for ischemic preconditioning, short episodes of ischemia and reperfusion that protect the heart against a subsequent prolonged ischemic insult. The team currently is exploring the cellular and molecular mechanisms underlying ischemic preconditioning using mice in which HIF-1 activity has been knocked out in specific cell types within the heart.

The team now is using mass spectroscopy techniques to identify proteins that interact with the HIF-1 subunit. By employing this taking proteomics-based approach, they have identified novel regulators of HIF-1 transcriptional activity as well as direct regulation of the DNA replication machinery by HIF-1.

Additional information

Meet Dr. Semenza

Q and A: On how doping in endurance sports and treating cardiovascular disease are interrelated

On being a scientist: 


On HIF-1: 


Titles
Professor of Pediatrics 
Professor of Medicine 
Professor of Oncology 
Professor of Radiation Oncology 
Professor of Biological Chemistry 
Director, Vascular Program, Institute for Cell Engineering

Graduate programs
Cellular and Molecular Medicine
Human Genetics and Molecular Biology

Publications
View a list of publications on PubMed.

Highly Cited by Thomson Reuters

Contact information
Phone: 443-287-5619
Fax: 443-287-5618
Email: gsemenza@jhmi.edu

 
 
 

 

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424

 

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer